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Background and purpose — In Malawi, both skeletal 
traction (ST) and intramedullary nailing (IMN) are used in 
the treatment of femoral shaft fractures, ST being the main-
stay treatment. Previous studies have found that IMN has 
improved outcomes and is less expensive than ST. However, 
no cost-effectiveness analyses have yet compared IMN and 
ST in Malawi. We report the results of a cost-utility analysis 
(CUA) comparing treatment using either IMN or ST.
Patients and methods — This was an economic evalu-
ation study, where a CUA was done using a decision-tree 
model from the government healthcare payer and societal 
perspectives with an 1-year time horizon. We obtained EQ-
5D-3L utility scores and probabilities from a prospective 
observational study assessing quality of life and function in 
187 adult patients with femoral shaft fractures treated with 
either IMN or ST. The patients were followed up at 6 weeks, 
and 3, 6, and 12 months post-injury. Quality adjusted life 
years (QALYs) were calculated from utility scores using the 
area under the curve method. Direct treatment costs were 
obtained from a prospective micro costing study. Indirect 
costs included patient lost productivity, patient transporta-
tion, meals, and childcare costs associated with hospital stay 
and follow-up visits. Multiple sensitivity analyses assessed 
model uncertainty.
Results — Total treatment costs were higher for ST 
($1,349) compared with IMN ($1,122). QALYs were lower 
for ST than IMN, 0.71 (95% confidence interval [CI] 0.66–
0.76) and 0.77 (CI 0.71–0.82) respectively. Based on lower 
cost and higher utility, IMN was the dominant strategy. IMN 
remained dominant in 94% of simulations. IMN would be 
less cost-effective than ST at a total procedure cost exceed-
ing $880 from the payer’s perspective, or $1,035 from the 
societal perspective.
The incidence of femoral shaft fractures in low- and middle-
income countries (LMICs) is estimated to range from 16 to 46 
per 100,000 people per year (Agarwal-Harding et al. 2015). 
In Malawi, which has 17.5 million inhabitants (National Sta-
tistical Office of Malawi 2019), a recent study estimated the 
prevalence of femoral shaft fractures at 1.4 per 100,000 people 
and incidence of 27 per 100,000 people per year (Agarwal-
Harding et al. 2020), translating into approximately 4,700 
fractures annually. For comparison, the annual incidence of 
femoral shaft fractures in Sweden is one third of that in Malawi 
(personal communication, Michael Möller, The Swedish 
Fracture Registry). The goal of treatment for these fractures 
is to achieve stability at the fracture site, thereby promoting 
union and painless weight-bearing, and allowing early patient 
rehabilitation. Treatment with intramedullary nailing (IMN) 
achieves this goal earlier and more consistently than skeletal 
traction (ST), and has become the gold standard for managing 
these fractures in high-income countries. In Malawi, however, 
treatment using ST, requiring patient immobilization in bed 
for at least 6 weeks, remains the mainstay treatment. 
Femoral shaft fractures do not only affect physical func-
tion, but also the patient’s social and psychological well-being 
(Haug et al. 2017, Kohler et al. 2017). Accordingly, better 
treatment of these fractures should improve quality of life by 
improving not only physical function but also social and psy-
chological functions. A quality adjusted life year (QALY) is 
Interpretation — IMN was cost saving and more effec-
tive than ST in the treatment of adult femoral shaft fractures 
in Malawi, and may be an efficient use of limited healthcare 
resources.
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an appropriate measure of outcome as it includes both quantity 
and quality of life (Stothers 2006). Studies from Malawi and 
elsewhere have found that treatment with IMN is less costly 
compared with ST (Gosselin et al. 2009, Opondo et al. 2013, 
Kamau et al. 2014, Diab et al. 2019). However, these studies 
did not assess the effectiveness of these 2 treatment modali-
ties using a generic outcome measure such as the QALY. As 
such it remains unclear which modality represents a better use 
of limited healthcare resources in terms of costs and QALYs 
gained. Malawi is a low-income country in Southern Africa 
with a gross domestic product (GDP) per capita of only US$ 
380  (World Bank 2019a). In a resource-limited setting like 
Malawi, appropriate resource allocation to ensure optimiza-
tion of the healthcare budget is a priority. Cost-effectiveness 
analyses of health care interventions can provide the neces-
sary evidence needed to change clinical practice, funding, and 
policies for the better. 
We evaluated the cost-effectiveness of IMN versus ST in the 
treatment of femoral shaft fractures in Malawi using QALYs 
as a measure of effectiveness, to determine which treatment 
modality best represents efficient use of healthcare resources 
from government healthcare payer and societal perspectives. 
Patients and methods
Design and setting
This study is a cost-utility analysis (CUA) comparing IMN 
with ST for treatment of adult femoral shaft fractures in 
Malawi. This was a planned analysis using data from a pre-
viously published prospective observational study that com-
pared quality of life (QOL) and function for adults with closed 
femoral shaft fractures treated with IMN or ST in Malawi 
(Chokotho et al. 2020). Adult patients were recruited from 
6 hospitals in Malawi: Queen Elizabeth Central Hospital 
(QECH), Kamuzu Central Hospital, Beit Cure International 
Hospital, and Chiradzulu, Thyolo, and Chikwawa district hos-
pitals. Patients were excluded using the following criteria: (1) 
age less than 18 (n = 4), (2) polytrauma or multiple injuries, 
defined as any additional injury requiring admission on its own 
merits (admission was used as a proxy for severity of injury 
since it was not possible to calculate injury severity scores; n 
= 7), (3) pathological fractures (n = 2), (4) open fractures (n = 
5), (5) clinical evidence of infection at the surgical site before 
or during surgery (n = 1), and (6) prior surgery involving the 
affected femur (n = 1). 
Study participants were treated using ST or IMN at the dis-
cretion of the treating surgeon or orthopedic clinical officer 
(OCO). OCOs are non-physician clinicians trained to provide 
nonoperative care for orthopedic conditions and emergency 
orthopedic surgery for selected cases, such as acute infec-
tions and open fractures (Mkandawire et al. 2008). Follow-up 
assessments for both groups were performed at 6 weeks, 3 
months, 6 months, and 1 year after the injury. At each follow-
up, the patients were assessed clinically, the EQ-5D-3L was 
administered, and radiographs taken when feasible. 
Treatment technique
The SIGN nail (Zirkle and Shahab 2016) was used in all IMN 
patients. This is a solid locking IM nail that can be inserted 
without the need for a fracture table or intraoperative fluo-
roscopy. The SIGN nail was inserted antegrade using open 
reduction, with the patient in the lateral position on a standard 
operating table. 
All ST patients had straight leg extension skeletal traction 
with a Steinmann pin inserted into the proximal tibia under 
local anesthesia, using an aseptic technique and a stirrup to 
connect the rope that was used to position the weights. The 
weights were positioned either using a bar or pulleys, or by 
placing the rope directly over the end of the bed, depending on 
the type of bed and equipment available at the hospital. 
Effectiveness data
We measured the effectiveness of each treatment strategy 
using quality-adjusted life years (QALYs) based on the EQ-
5D-3L (Rabin and Charro 2001). At each follow-up time 
point, research assistants administered the EQ-5D-3L ques-
tionnaire to the study participants. The EQ-5D-3L is a tool 
used to measure health-related quality of life (HRQoL) that 
has been translated to Chichewa and validated for use in 
Malawian orthopedic patients (Chokotho et al. 2017). Util-
ity scores were calculated using EQ-5D-3L responses based 
on data from the Zimbabwean population value set (Jelsma 
et al. 2003). QALYs were calculated from the utility scores 
using the area under the curve (AUC) method (Billingham 
et al. 1999). The AUC was calculated by multiplying the 
EQ-5D score at each time point by the midpoint duration 
between follow-up visits to capture both pre- and post-visit 
health states. We calculated QALYs for each of the 4 health 
states (successful IMN, unsuccessful IMN, successful skele-
tal traction, and unsuccessful skeletal traction). There was no 
measurable difference between groups in EQ-5D-3L index 
score at 1 year after treatment, hence a 1-year time horizon 
was used. 
Costing data
Direct medical and overhead costs and indirect patient costs 
were estimated. Direct costs were estimated using time-and-
motion analysis and included procedure personnel and sup-
plies; ward personnel; medications and investigations; surgi-
cal implants; and instruments. Even though the SIGN nail is 
distributed free of charge in LMICs, to be more conservative 
in our economic analysis we included the hardware produc-
tion cost, which was obtained directly from the manufacturer. 
The figure includes both manufacturing and distribution 
costs. Overhead costs included food, building maintenance, 
renovation, cleaning and sanitation, bedding, stationery, uni-
forms, protective wear, and staff training. The direct medical 
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and follow-up visits. We calculated costs associated with lost 
productivity for patients who reported either formal or infor-
mal employment prior to injury. Employment was scored 
as a binary value at each follow-up time point. Using mid-
points between follow-up visits before and after the follow-
up time point, overall lost productivity was weighted by the 
sum of weeks of reported unemployment, with a maximum 
of 52 weeks. The costs associated with productivity loss were 
calculated using a standardized wage for Malawi, adjusted 
using purchasing power parity to US$ (World Bank 2019b). 
Patients were interviewed to estimate transportation, meal, 
and childcare costs. Resource utilization for each treatment 
group is given in Table 1.
Decision-tree model
We constructed a simple decision-tree model (Figure 1) 
to compare the 2 treatments using TreeAge Pro 2020 (Pro 
2019). In the ST treatment strategy, there were 2 potential 
outcomes: (1) successful traction, or (2) failure of treatment 
with conversion to IMN. Successful traction was defined 
as complete fracture union after treatment with ST. Fail-
ure of ST treatment was defined as either delayed union 
or non-union of the fracture requiring conversion to IMN. 
Patients treated in the IMN group had 2 potential outcomes: 
(1) successful IMN, or (2) failure of treatment with reop-
eration. The diagnosis of delayed union was made by the 
treating clinician if, at 6 weeks or more post-injury, there 
Table 1. Resource utilization for each treatment group 
including both direct and indirect costs excluding the 
cost of failed traction or surgery requiring reoperation 
expressed as US$ 
 Factor  IMN ST
Direct costs  
 Inpatient  
  Ward personnel 264 445
  Overhead 116 196
  Surgical implants 136 0.0
  Investigations 38 288
  Procedure personnel 24 2.7
  Procedure supplies 8.5 3.6
  Instruments 8.7 0.2
  Medications 2.2 1.6
  Total 597 678
 Outpatient  
  Clinic personnel 1.0 0.8
  Physiotherapy personnel 2.6 1.2
  Radiography 41 29
  Total 45 31
 Total direct costs 642 709
Indirect costs  
  Lost productivity 454 610
  Transportation 4.0 4.0
  Meals 3.4 0.7
  Childcare costs 20 25
 Total indirect costs 480 640

















Figure 1. Decision-tree model of possible outcomes after ST and IMN treatment of 
femoral shaft fractures. Costs and effectiveness of each pathway are presented at 
the end of each potential pathway.
Table 2. Inputs for the decision-tree model
    Distribution
Factor  Mean (95% CI) SE type Ref. a
Costs     
 IMN     
  Direct inpatient cost 597 (543–651) 27 Gamma D
  Direct outpatient cost  45       – – – C
  Cost of reoperation  900 (600–1,200) – Uniform b
  Indirect cost (societal) 480       – – – C
 ST    
  Direct inpatient cost  678 (624–732) 28 Gamma D
  Direct outpatient cost 31       – – – C
  Cost of IMN after failed ST 649 (563–735) 49 Gamma D
  Indirect cost (societal) 640       – – – C
Utilities      
 IMN     
  Utility successful IMN 0.77 (0.72–0.83) 0.03 Beta C
  Utility after reoperation 0.71 (0.61–0.81) 0.05 Beta E
 ST     
  Utility successful ST 0.72 (0.66–0.79) 0.03 Beta C
  Utility failed ST 0.69 (0.61–0.76) 0.04 Beta C
Probabilities (%)     
 IMN     
  Probability reoperation 1.8 (0.0–5.3) 0.02 Beta C
 ST     
    Probability failed ST 30 (22–38) 0.04 Beta C
a C – Chokotho et al. 2020; D – Diab et al. 2019; E – Eliezer et al. 2017
b Assumed reoperation cost 1- to 2-fold higher than index surgery.
and overhead cost data was collected on a subset 
of patients in the main clinical study at 1 of the 6 
sites (QECH) (Diab et al. 2019). Hourly salaries 
for personnel were calculated by dividing mean 
annual salary by the product of 9-hour days, which 
is the average working hours for public hospitals 
in Malawi, and 251 working days per year. Fur-
ther details on how the direct costs were calculated 
have been published earlier (Diab et al. 2019). 
All costs were presented in 2017 US$. Outpatient 
costs included clinic personnel, physiotherapy, and 
radiography costs. Indirect costs included patient 
lost productivity, and patient transportation, meals, 
and childcare costs associated with hospital stay 
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was still tenderness and mobility at the fracture site and no 
 radiological evidence of callus formation. Non-union was 
defined as no evidence of fracture healing both clinically 
and radiologically after at least 3 months on ST or 6 months 
after IMN.
The primary outcome of the analysis was the incremen-
tal cost-effectiveness ratio (ICER), which was calculated 
by dividing the difference in cost by the difference in utility 
between the 2 treatment groups. The inputs for the model are 
given in Table 2. There was no difference in EQ-5D-3L index 
scores at 1 year in the primary study, hence a 1-year time hori-
zon was used. Although typically 3% discounting would be 
applied, because of the 1-year time horizon we did not apply 
discounting. Both payer and societal perspectives were con-
sidered in the base case. 
Sensitivity analysis
We made both deterministic and probabilistic sensitivity 
analyses to assess which parameters are most important for 
the ICER and the uncertainty of the ICER input parameters. A 
tornado diagram was used to perform multiple 1-way sensi-
tivity analyses assessing the relative influence of each model 
input on the ICER across a range of plausible input values 
based on the upper and lower limits of 95% confidence inter-
vals (CI). 1-way sensitivity analyses were presented indepen-
dently where appropriate. A multivariate probabilistic sensi-
tivity analysis (PSA) was completed by performing 10,000 
iterations of the model with a unique value for each input 
drawn from a probability distribution. The distributions used 
and standard errors are shown in Table 2. In general, costs 
were represented using a gamma distribution (range 0 to ∞) 
while probabilities and utilities were represented with a beta 
distribution (range 0 to 1). The results of the PSA are pre-
sented as an ICER scatter plot, which visually demonstrates 
the outcome of each iteration of the PSA as a point on the 
cost-effectiveness plane. 
Ethics, funding, and potential conflicts of interest
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Results
We used data from 187 patients who completed 1-year follow-
up to estimate utilities and probabilities, including 55 cases 
treated with a SIGN intramedullary nail (IMN) and 132 cases 
treated with ST. The overall total QALYs at 1 year were higher 
after IMN compared with ST (Table 3). 
We used data on a subset of 65 patients treated at QECH 
(38 IMN, 27 ST) to estimate direct costs. The total direct 
cost of treatment was higher in the ST group compared with 
IMN (see Table 3). The total societal cost was higher for ST 
($1,543; CI $1,149–$1,625) than IMN (1,139; CI $1,080–
$1,210). Based on higher costs from both payer and societal 
perspectives, and lower utility with ST, IMN was the domi-
nant strategy.
Sensitivity analysis
The Tornado diagram (Figure 2) shows that the ICER was 
most sensitive to effectiveness of successful IMN, followed 
by effectiveness of successful traction. No change in the range 
of values for any of the variables resulted in IMN being less 
cost-effective than ST.
Table 3. Output from decision-tree model including 
incremental cost (US$) and effectiveness with 95% 
confidence intervals 
   
       
Skeletal traction 
 Utility 0.71 (0.66–0.76)  
 Payer  cost 903 (828–986)
 Societal cost  1,543 (1,469–1,625)
Early IMN
 Utility 0.77 (0.71–0.82)  
 Payer cost 659 (599–729)
 Societal cost 1,139 (1,080–1,210)
Incremental utility 0.06   
Incremental payer cost –244  
Incremental societal cost –404 
Utility of successful IMN (0.72–0.83)
Utility of IMN requiring reoperation (0.61–0.81)
Utility of successful traction (0.79–0.66)
Utility of failed traction converted to IMN (0.76–0.61)
Cost of IMN (543–651)
Cost of reoperation (600–1,200)
Cost of traction (732–624)
Outpatient cost of IMN (0–90)
Outpatient cost of traction (62–0)
Probability of failed traction (0.378–0.222)
Probability of reoperation (0–0.053)
–1x105 0–2x105–3x105–4x105
ICER
Figure 2. Tornado diagram demonstrating influence of each variable on the ICER 
across a plausible range of inputs based on the upper and lower bound of 95% con-
fidence interval. Dotted line represents ICER per QALY gained for the base case.
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Figures 3 and 4 show the 1-way sensitivity analysis varying 
the total cost of IMN on ICER from the payer and societal 
perspectives respectively. IMN was dominant (more effective, 
less costly) up to a total procedure cost of $880 from the payer 
perspective or $1,035 from the societal perspective. Focusing 
specifically on the cost of the intramedullary implant, surgery 
was cost saving up to a nail cost of $472 from the payer per-
spective or $691 from a societal perspective. 
Probabilistic sensitivity analysis
The ICER scatter plot (Figure 5) shows that IMN was cost 
saving and more effective (dominant) in 93.8% of simulations. 
Discussion
This study found that treatment of adult femoral shaft fractures 
with IMN was more cost-effective than with ST in Malawi. 
Sensitivity analyses showed more than 90% certainty that this 
conclusion is true, and will remain true for IMN procedural 
costs of less than $880 and $1,035 from the payer and societal 
perspectives, respectively. Although there were no substantial 
differences in effectiveness between treatment modalities at 1 
year, there were small differences at the other time intervals 
(Chokotho et al. 2020). The cost of IMN was lower and util-
ity higher compared with ST; IMN is therefore the dominant 
approach from both societal and payer perspectives. 
The finding of lower cost of IMN compared with ST has 
been reported by previous studies. Gosselin et al. (2009) found 
lower costs for IMN compared with ST, even after accounting 
for re-nailing costs following infection or non-union. Gosselin 
also reported better union rates with IMN than ST. Similarly, 
both Opondo et al. (2013) and Kamau et al. (2014) found IMN 
to be less costly with better healing and functional outcomes 
than ST among patients with femoral shaft fractures in Kenya. 
However, the time horizon in these studies ranged from 12 to 
16 weeks, limiting the assessment of non-union. Further, there 
was no measure of patient-reported outcomes or preference-
weighted instruments, such as the EQ-5D, and cost was mea-
sured only from the payer perspective. While our study found 
similar EQ-5D scores between the 2 groups at 1-year follow-
up, a high percentage (30%) of the patients treated with ST 
required conversion to IM nailing due to either delayed union 
or non-union (Chokotho et al. 2020). Had these patients not 
converted to IM nailing, it is likely that they would have had 
substantially worse EQ-5D scores at 1-year, meaning this 
conversion likely mitigated some of the negative effects as 
patients were “rescued” from skeletal traction complications 
by conversion to IMN. In this sense, the conversion biased the 
effectiveness estimate towards the null hypothesis. 
Patients treated with ST in Malawi are normally admitted 
to hospital for at least 6 weeks whereas those treated with 
IMN have an average length of stay of 17 days (Diab et al. 
2019). In Malawi, patients do not pay service fees in public 
hospitals, therefore prolonged hospital stay is likely to have 
cost implications from the governmental payer perspective. 
A treatment method like IMN, which is both cost-saving and 
more effective, is certainly worth prioritizing to optimize the 
limited health budget. 
Prolonged hospital stay is also likely to have financial 
implications for the patients and their guardians, who usually 
accompany patients in the hospital during the entire admission 
period. Due to the lack of nursing staff in Malawi, it is custom-
ary for these guardians, who are typically family members, to 
serve as the primary caregiver for patients during their hos-
pitalization, with both patients and caregivers incurring sub-
stantial indirect costs of lost productivity, and hospital-related 
expenses. This is the first study that has evaluated the cost-
effectiveness of femoral shaft fracture treatment with IMN 
and ST from the societal perspective. Haug et al. (2017) found 
that patients treated with skeletal traction complained that pro-
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Figure 3. 1-way sensitivity analysis on the 
payer total cost of early intramedullary nail-
ing and ICER.
Figure 4. 1-way sensitivity analysis on the 
societal total cost of early intramedullary 
nailing and ICER.
Figure 5. ICER scatter plot demonstrating output 
from the probabilistic sensitivity analysis.
6 Acta Orthopaedica 2021; 92 (x): x–x
patients and their families were unable to engage in income-
generating activities. In addition, they found that there was 
increased out-of-pocket expenditure while in hospital. Sur-
vival mechanisms to keep up with the increased expenditure 
included selling their property and borrowing money, some-
times with high interest rates (Damme et al. 2004, Kohler et 
al. 2017). Therefore, if hospital stays can be reduced through 
IMN, this treatment has cost-saving potential from both the 
governmental payer and the societal perspective. 
SIGN Fracture Care International currently donates intra-
medullary nails free of charge to many hospitals in LMICs, 
including Malawi. This fact increases the potential cost saving 
beyond this study’s estimates, since our analysis included the 
cost of the IM nail. Cost-effective interventions are, however, 
not always affordable and accessible, and such is the case for 
Malawi where provision of operative fracture treatment is not 
universal in public hospitals. Future studies should include 
budget impact analyses assessing the affordability of adopting 
a new intervention from the payer’s perspective (Sullivan et al. 
2014), thereby evaluating the opportunity costs and relevant 
benefits associated with choosing IM nailing as first-line treat-
ment over ST. 
Our study had several limitations. First, as it was not a 
randomized study, there were likely unmeasured confound-
ing variables. However, the body of evidence supporting IM 
nailing (Amihood 1973, Gosselin et al. 2009, Opondo et al. 
2013, Kamau et al. 2014), would likely make an RCT unethi-
cal to perform. Second, loss to follow-up at the different time 
points could lead to selection bias, thereby affecting our find-
ings. However, there was no differential loss to follow-up as 
the proportions in both groups were similar. The results in our 
model were validated by univariate sensitivity analysis and 
probabilistic sensitivity analysis and both analyses showed 
that IMN was the cost-effective treatment approach. Third, the 
time horizon of 1 year used in this study may have been too 
short. As such we may have missed long-term QALY gains. 
However, effectiveness was similar between the 2 treatment 
groups at 1 year, likely because those who failed ST treat-
ment, and were likely to have a poor outcome if left untreated, 
were switched to treatment with IMN. Conversely, in a setting 
where IMN is not offered, ST is likely to result in substantial 
loss of QALYs. Another limitation is that the decision tree in 
our analysis did not include all possible pathways or compli-
cations that represent the course of outcomes after treatment. 
Only delayed union and non-union were considered because 
cost data for other complications was not available. The major-
ity of patients in this study were recruited from government-
run hospitals, and so the findings may not be applicable to 
patients treated in private care facilities. However, ST treat-
ment is not routinely offered in private hospitals, where all 
patients are treated with IMN, and the majority of the popula-
tion in Malawi does not have medical insurance and therefore 
uses public hospitals where services are free at point of care. 
Thus, our findings are applicable to the majority of health 
facilities in the country. 
In conclusion, despite its limitations, our study has shown 
that IMN is more effective and costs less than ST, and therefore 
scale-up of IMN may be an efficient use of limited healthcare 
resources in low-income countries. Our findings are relevant 
to healthcare policymakers and other stakeholders to justify 
and advocate for improved surgical capacity so that patients 
with femoral shaft fractures are treated with intramedullary 
nailing rather than skeletal traction. 
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